Hyperkalemia as a constraint to therapy with combination Renin-Angiotensin system blockade: the elephant in the room.
Epstein
Murray
M
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000075202:Contraindications; D005919:Glomerular Filtration Rate; D006801:Humans; D006947:Hyperkalemia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D011188:Potassium / Q000097:blood; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D011188:Potassium